Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel therapeutic targets for hypertension.
Paulis L, Unger T. Paulis L, et al. Nat Rev Cardiol. 2010 Aug;7(8):431-41. doi: 10.1038/nrcardio.2010.85. Epub 2010 Jun 22. Nat Rev Cardiol. 2010. PMID: 20567239 Review.
The angiotensin AT2 receptor in left ventricular hypertrophy.
Steckelings UM, Widdop RE, Paulis L, Unger T. Steckelings UM, et al. Among authors: paulis l. J Hypertens. 2010 Sep;28 Suppl 1:S50-5. doi: 10.1097/01.hjh.0000388495.66330.63. J Hypertens. 2010. PMID: 20823717 Review.
Emerging drugs which target the renin-angiotensin-aldosterone system.
Steckelings UM, Paulis L, Unger T, Bader M. Steckelings UM, et al. Among authors: paulis l. Expert Opin Emerg Drugs. 2011 Dec;16(4):619-30. doi: 10.1517/14728214.2011.618495. Epub 2011 Sep 12. Expert Opin Emerg Drugs. 2011. PMID: 21905943 Review.
AT2 receptor agonists: hypertension and beyond.
Steckelings UM, Paulis L, Namsolleck P, Unger T. Steckelings UM, et al. Among authors: paulis l. Curr Opin Nephrol Hypertens. 2012 Mar;21(2):142-6. doi: 10.1097/MNH.0b013e328350261b. Curr Opin Nephrol Hypertens. 2012. PMID: 22257799
Key advances in antihypertensive treatment.
Paulis L, Steckelings UM, Unger T. Paulis L, et al. Nat Rev Cardiol. 2012 Mar 20;9(5):276-85. doi: 10.1038/nrcardio.2012.33. Nat Rev Cardiol. 2012. PMID: 22430830 Review.
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.
Slavic S, Lauer D, Sommerfeld M, Kemnitz UR, Grzesiak A, Trappiel M, Thöne-Reineke C, Baulmann J, Paulis L, Kappert K, Kintscher U, Unger T, Kaschina E. Slavic S, et al. Among authors: paulis l. J Mol Med (Berl). 2013 Jul;91(7):811-23. doi: 10.1007/s00109-013-1034-0. Epub 2013 May 1. J Mol Med (Berl). 2013. PMID: 23636507
106 results